Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs-Reference-Cited by-同舟云学术

Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs

Published:2010-07 Issue:7 Volume:18 Page:1318-1329
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Haurigot Virginia,Mingozzi Federico,Buchlis George,Hui Daniel J,Chen Yifeng,Basner-Tschakarjan Etiena,Arruda Valder R,Radu Antoneta,Franck Helen G,Wright J Fraser,Zhou Shangzhen,Stedman Hansell H,Bellinger Dwight A,Nichols Timothy C,High Katherine A

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy;Jiang;Blood,2006

2. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver;Mingozzi;Blood,2007

3. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial;Maguire;Lancet,2009

4. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial;Kaplitt;Lancet,2007

5. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy;Brantly;Proc Natl Acad Sci USA,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of Humoral Response to Transgene Protein and Gene Editing Reagents;Drug Development for Gene Therapy;2024-02-16

2. Infusion reactions to adeno‐associated virus (AAV)‐based gene therapy: Mechanisms, diagnostics, treatment and review of the literature;Journal of Medical Virology;2023-12

3. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy;Science Translational Medicine;2023-01-04

4. Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy;Human Gene Therapy;2022-09-01

5. Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety;Progress in Retinal and Eye Research;2021-07